Inventor · disambiguated record
Yannick Doyon
Also filed as: DOYON YANNICK
17 granted patents·5 pending applications·322 citations·filing 2008–2022
94Inventor score
Top patents by PatentIndex Score
22 records- 0198US8623618B2Engineered cleavage half-domainsDOYON YANNICK·Filed 2011·Granted Jan 7, 2014·141 cites·18 claims
- 0297US8962281B2Engineered cleavage half-domainsDOYON YANNICK·Filed 2011·Granted Feb 24, 2015·66 cites·20 claims
- 0395US9376689B2Engineered cleavage half-domainsSANGAMO BIOSCIENCES INC·Filed 2015·Granted Jun 28, 2016·8 cites·21 claims
- 0494US10066242B2Artificial nucleases comprising engineered cleavage half-domainsSANGAMO THERAPEUTICS INC·Filed 2017·Granted Sep 4, 2018·5 cites·18 claims
- 0593US8772008B2Methods and compositions for increasing nuclease activityDOYON YANNICK·Filed 2010·Granted Jul 8, 2014·19 cites·4 claims
- 0692US11136599B2Artifical nucleases comprising engineered cleavage half-domainsSANGAMO THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·2 cites·9 claims
- 0792US9765361B2Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cellSANGAMO BIOSCIENCES INC·Filed 2016·Granted Sep 19, 2017·5 cites·15 claims
- 0892US8329986B2Targeted integration into the Zp15 locusBUTLER HOLLY J·Filed 2009·Granted Dec 11, 2012·50 cites·15 claims
- 0991US10640790B2Artificial nucleases including engineered FokI cleavage half-domainsSANGAMO THERAPEUTICS INC·Filed 2018·Granted May 5, 2020·3 cites·10 claims
- 1090US9150879B2Engineered cleavage half-domainsSANGAMO BIOSCIENCES INC·Filed 2014·Granted Oct 6, 2015·5 cites·14 claims
- 1188US9121072B2Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsHOLMES MICHAEL C·Filed 2011·Granted Sep 1, 2015·5 cites·17 claims
- 1288US9115409B2Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsSANGAMO BIOSCIENCES INC·Filed 2013·Granted Aug 25, 2015·4 cites·15 claims
- 1387US9506120B2Rapid in vivo identification of biologically active nucleasesDOYON YANNICK·Filed 2008·Granted Nov 29, 2016·6 cites·10 claims
- 1481US8772009B2Methods and compositions for increasing nuclease activityDOYON YANNICK·Filed 2011·Granted Jul 8, 2014·3 cites·5 claims
- 1580US11725218B2Artificial nucleases comprising engineered cleavage half-domainsSANGAMO THERAPEUTICS INC·Filed 2021·Granted Aug 15, 2023·0 cites·18 claims
- 1668US10827731B2Method of inactivating the IPK1 gene in cornSANGAMO THERAPEUTICS INC·Filed 2018·Granted Nov 10, 2020·0 cites·4 claims
- 1763US2013198878A1Organisms homozygous for targeted modificationC O SANGAMO BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 1861US2024352487A1Mtor -targeted modification and uses thereofUNIV LAVAL·Filed 2022·Application pending·0 cites
- 1959US12378549B2CRISPR-cas9 system and uses thereofUNIV LAVAL·Filed 2019·Granted Aug 5, 2025·0 cites·6 claims
- 2058US2009203140A1Genomic editing in zebrafish using zinc finger nucleasesUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 2157US2011247089A1Organisms homozygous for targeted modificationSANGAMO BIOSCIENCES INC·Filed 2011·Application pending·0 cites
- 2256US2011041195A1Organisms homozygous for targeted modificationSANGAMO BIOSCIENCES INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yannick Doyon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →